It’s time to bring life sciences real estate to investors.
2021 was the year of life sciences real estate and we did three research projects one after the other on this fast-growth sector. The first two were for the Urban Land Institute and were regional scale in scope, covering Europe first and then Asia Pacific. The third project was much more granular and focused exclusively on four cities in Ireland: Cork, Dublin, Galway and Limerick.
Looking back on the notes from those research projects, one thing really stands out – the lack of understanding between the occupiers and operators on one hand and the developers and investors on the other. There are some notable exceptions, of course, but in many instances, it’s as if the two sectors were speaking different languages, particularly when it came to the smaller start-up and scale-up companies working at the R&D phase of life sciences.
